AxoGen (AXGN) Competitors $13.34 +0.24 (+1.83%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AXGN vs. ZYXI, NTUS, IART, IRTC, CNMD, TNDM, NVCR, RXST, INMD, and MDXGShould you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include Zynex (ZYXI), Natus Medical (NTUS), Integra LifeSciences (IART), iRhythm Technologies (IRTC), CONMED (CNMD), Tandem Diabetes Care (TNDM), NovoCure (NVCR), RxSight (RXST), InMode (INMD), and MiMedx Group (MDXG). These companies are all part of the "medical" sector. AxoGen vs. Zynex Natus Medical Integra LifeSciences iRhythm Technologies CONMED Tandem Diabetes Care NovoCure RxSight InMode MiMedx Group Zynex (NASDAQ:ZYXI) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends. Which has better earnings & valuation, ZYXI or AXGN? Zynex has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZynex$184.32M1.43$9.73M$0.1555.07AxoGen$180.86M3.25-$21.72M-$0.32-41.69 Does the MarketBeat Community believe in ZYXI or AXGN? AxoGen received 425 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 72.71% of users gave AxoGen an outperform vote while only 57.14% of users gave Zynex an outperform vote. CompanyUnderperformOutperformZynexOutperform Votes2857.14% Underperform Votes2142.86% AxoGenOutperform Votes45372.71% Underperform Votes17027.29% Which has more risk and volatility, ZYXI or AXGN? Zynex has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Do analysts prefer ZYXI or AXGN? Zynex currently has a consensus price target of $14.00, suggesting a potential upside of 69.49%. AxoGen has a consensus price target of $15.00, suggesting a potential upside of 12.44%. Given Zynex's higher probable upside, equities research analysts plainly believe Zynex is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00AxoGen 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in ZYXI or AXGN? 29.7% of Zynex shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 52.1% of Zynex shares are held by insiders. Comparatively, 7.0% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is ZYXI or AXGN more profitable? Zynex has a net margin of 2.49% compared to AxoGen's net margin of -7.91%. Zynex's return on equity of 13.05% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets Zynex2.49% 13.05% 3.78% AxoGen -7.91%-14.91%-7.49% Does the media favor ZYXI or AXGN? In the previous week, AxoGen had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for AxoGen and 0 mentions for Zynex. AxoGen's average media sentiment score of 0.95 beat Zynex's score of -0.55 indicating that AxoGen is being referred to more favorably in the news media. Company Overall Sentiment Zynex Negative AxoGen Positive SummaryZynex beats AxoGen on 9 of the 17 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXGN vs. The Competition Export to ExcelMetricAxoGenElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$587.07M$3.46B$5.38B$8.84BDividend YieldN/A1.70%5.13%4.09%P/E Ratio-41.6918.72105.1417.83Price / Sales3.2567.101,233.15158.41Price / CashN/A47.0340.4136.29Price / Book5.904.047.096.50Net Income-$21.72M$89.83M$119.65M$226.22M7 Day Performance5.54%0.51%2.25%4.03%1 Month Performance1.68%6.35%-2.33%4.92%1 Year Performance126.10%21.27%33.98%29.30% AxoGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXGNAxoGen2.7069 of 5 stars$13.34+1.8%$15.00+12.4%+126.1%$587.07M$180.86M-41.69426ZYXIZynex3.7405 of 5 stars$8.24+1.6%$14.00+69.9%-9.0%$262.44M$184.32M54.201,100NTUSNatus MedicalN/A$32.96flatN/A+0.0%$1.14B$473.44M89.081,400Analyst ForecastIARTIntegra LifeSciences2.8749 of 5 stars$23.51+2.2%$24.00+2.1%-39.8%$1.81B$1.54B-255.533,946Positive NewsIRTCiRhythm Technologies3.0828 of 5 stars$73.65-0.3%$108.50+47.3%-14.8%$2.31B$560.03M-15.272,000CNMDCONMED4.5862 of 5 stars$73.31+2.2%$79.80+8.9%-30.5%$2.26B$1.24B17.004,000Positive NewsTNDMTandem Diabetes Care4.769 of 5 stars$30.52-0.7%$54.25+77.8%+61.8%$2.00B$747.72M-15.932,400Insider TradeNews CoveragePositive NewsNVCRNovoCure3.8577 of 5 stars$17.67+3.4%$26.17+48.1%+48.7%$1.91B$509.34M-12.211,453Analyst ForecastNews CoverageRXSTRxSight3.0594 of 5 stars$45.43+0.8%$61.63+35.6%+57.1%$1.83B$89.08M-55.19220INMDInMode2.0838 of 5 stars$18.83+1.8%$22.60+20.0%-18.0%$1.58B$492.05M9.99480MDXGMiMedx Group3.1211 of 5 stars$9.15-0.8%$12.00+31.1%+21.5%$1.34B$321.48M16.76895 Related Companies and Tools Related Companies ZYXI Alternatives NTUS Alternatives IART Alternatives IRTC Alternatives CNMD Alternatives TNDM Alternatives NVCR Alternatives RXST Alternatives INMD Alternatives MDXG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AXGN) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXGN Stock Alerts